Allakos Stock (NASDAQ: ALLK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 551.31K |
Day Range | - - - |
52 Wk Range | 0.54 - 3.41 |
Market Cap | $48.12M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 3.11% |
Days to Cover | 5.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Allakos (NASDAQ:ALLK) through any online brokerage.
Other companies in Allakos’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), OncoCyte (NASDAQ:OCX) and Intensity Therapeutics (NASDAQ:INTS).
Allakos has a consensus price target of $23.50.
The stock price for Allakos (NASDAQ: ALLK) is $0.5416 last updated September 23, 2024 at 7:02 PM EDT.
There are no upcoming dividends for Allakos.
Allakos’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Allakos.
Allakos is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.